With Sanofi on board, it’s a bigger digital healthcare ecosystem where information and data will be designed to share between FreeStyle Libre and our partner’s digital health tools, offering users personalized care.Īs the world leader in sensor-based glucose monitoring, the FreeStyle Libre system is improving the lives of more than 1.5 million people.
Those tools include connected apps, FreeStyle LibreLink (which helps you monitor your glucose via a smartphone) as well as Libre LinkUp (which allows your loved ones to view your results after you scan). “Building a digital ecosystem around FreeStyle Libre simplifies the user experience by consolidating how people get their data - both through offering Abbott’s digital health tools and by working with other diabetes and technology leaders.” It’s an information-rich condition with various streams of data from multiple devices,” said Jared Watkin, senior vice president, Diabetes Care, Abbott. And we all have one big goal in common: The commitment to employing life-changing technology to make diabetes management as simple, easy and effective as it can be. It’s a good group, this network of diabetes care experts. That’s why we started collaborating with Bigfoot and Novo Nordisk to connect our world-leading FreeStyle Libre flash glucose monitoring system with their world-class insulin delivery systems, including Bigfoot’s user-friendly systems intended to optimize insulin delivery as well as Novo Nordisk’s connected insulin pens.Īnd it’s why we’re now joining forces with Sanofi to integrate FreeStyle Libre technology with Sanofi’s insulin dosing information for future smart pens, insulin titration apps and cloud software.
0 kommentar(er)
